Exelixis price target raised to $27 from $25 at TD Cowen

TD Cowen analyst Yaron Werber raised the firm’s price target on Exelixis to $27 from $25 and keeps a Buy rating on the shares. The firm said investor focus remains on imminent MSN II decision this spring which Cowen thinks could favor Exelixis.